| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 100.16 mm | 100.16 mm | 100.16 mm | 100.16 mm | 100.16 mm | 100.16 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 4.35 mm | 4.54 mm | (no burn) | 2.22 mm |
| Cash used (since last report) | n/a | n/a | 12.18 mm | 12.71 mm | n/a | 6.23 mm |
| Cash remaining | n/a | n/a | 87.98 mm | 87.45 mm | n/a | 93.93 mm |
| Runway (months of cash) | n/a | n/a | 20.2 | 19.3 | n/a | 42.2 |
| 13F holders | Current |
|---|---|
| Total holders | 48 |
| Opened positions | 22 |
| Closed positions | 50 |
| Increased positions | 13 |
| Reduced positions | 7 |
| 13F shares | Current |
|---|---|
| Total value | 70.60 bn |
| Total shares | 12.65 mm |
| Total puts | 2.10 k |
| Total calls | 49.90 k |
| Total put/call ratio | 0.0 |
| Largest owners | Shares | Value |
|---|---|---|
| NEA Management | 2.37 mm | $28.42 bn |
| New Enterprise Associates 10 L P | 2.20 mm | $56.00 mm |
| Cooperatieve Gilde Healthcare IV U.A. | 1.83 mm | $46.63 mm |
| Vensana Capital I GP | 1.71 mm | $0.00 |
| Soleus Capital Master Fund | 1.01 mm | $0.00 |
| Soleus Capital Management | 587.10 k | $7.04 bn |
| Parkman Healthcare Partners | 447.62 k | $5.37 bn |
| Balyasny Asset Management | 443.11 k | $5.31 bn |
| Schonfeld Strategic Advisors | 398.47 k | $4.78 bn |
| Silvercrest Asset Management | 257.30 k | $3.08 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Nov 24 | Paul Verrastro | Common Stock | Gift | Dispose G | No | No | 0 | 1,040 | 0.00 | 835 |
| 19 Nov 24 | Paul Verrastro | Common Stock | Sell | Dispose S | No | No | 13.5781 | 1,430 | 19.42 k | 1,875 |
| 19 Nov 24 | Paul Verrastro | Common Stock | Option exercise | Acquire M | No | No | 5.141 | 2,500 | 12.85 k | 3,305 |
| 19 Nov 24 | Paul Verrastro | Stock Option Common Stock | Option exercise | Dispose M | No | No | 5.141 | 2,500 | 12.85 k | 73,306 |
| 3 Sep 24 | Kevin J. Ballinger | Stock Option Common Stock | Grant | Acquire A | No | No | 9.05 | 36,136 | 327.03 k | 36,136 |
| 3 Sep 24 | Hill, Mitch C. | Stock Option Common Stock | Grant | Acquire A | No | No | 9.05 | 36,136 | 327.03 k | 36,136 |
